APP Regulates Microglial Phenotype in a Mouse Model of Alzheimer's Disease
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
UNLABELLED: Prior work suggests that amyloid precursor protein (APP) can function as a proinflammatory receptor on immune cells, such as monocytes and microglia. Therefore, we hypothesized that APP serves this function in microglia during Alzheimer's disease. Although fibrillar amyloid β (Aβ)-stimulated cytokine secretion from both wild-type and APP knock-out (mAPP(-/-)) microglial cultures, oligomeric Aβ was unable to stimulate increased secretion from mAPP(-/-) cells. This was consistent with an ability of oligomeric Aβ to bind APP. Similarly, intracerebroventricular infusions of oligomeric Aβ produced less microgliosis in mAPP(-/-) mice compared with wild-type mice. The mAPP(-/-) mice crossed to an APP/PS1 transgenic mouse line demonstrated reduced microgliosis and cytokine levels and improved memory compared with wild-type mice despite robust fibrillar Aβ plaque deposition. These data define a novel function for microglial APP in regulating their ability to acquire a proinflammatory phenotype during disease. SIGNIFICANCE STATEMENT: A hallmark of Alzheimer's disease (AD) brains is the accumulation of amyloid β (Aβ) peptide within plaques robustly invested with reactive microglia. This supports the notion that Aβ stimulation of microglial activation is one source of brain inflammatory changes during disease. Aβ is a cleavage product of the ubiquitously expressed amyloid precursor protein (APP) and is able to self-associate into a wide variety of differently sized and structurally distinct multimers. In this study, we demonstrate both in vitro and in vivo that nonfibrillar, oligomeric forms of Aβ are able to interact with the parent APP protein to stimulate microglial activation. This provides a mechanism by which metabolism of APP results in possible autocrine or paracrine Aβ production to drive the microgliosis associated with AD brains.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 1×
“…that oligomeric A both in vitro (Roher et al., 1996; Lue et al., 1999; McLean et al., 1999) and in vivo (Cleary et al., 2005; Klyubin et al., 2005; Lesné et al., 2006) stimulate microglial activation, which is at least consistent with the notion that this form of the peptide is a…”
BackgroundRetractedJarrett, J. T., Berger, E. P., & Lansbury, P. T. (1993) · Biochemistry · doi:10.1021/bi00069a001 · Cited by 2,022 · cited 1×
“Amyloid precursor protein (APP) is a type I integral membrane protein that undergoes proteolysis via amyloidogenic or nonamyloidogenic pathways (Esch et al., 1990; Shoji et al., 1992; Haass and Selkoe, 1993; Haass et al., 1993; Jarrett et al., 1993).”
BackgroundSoluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530 · cited 1×
“In addition, others have shown that oligomeric A both in vitro (Roher et al., 1996; Lue et al., 1999; McLean et al., 1999) and in vivo (Cleary et al., 2005; Klyubin et al., 2005; Lesné et al., 2006) stimulate microglial activation, which is at least consistent with the notion that this form of the…”
BackgroundProduction of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing
Shoji, M., Golde, T. E., Ghiso, J., Cheung, T. T., Estus, S., Shaffer, L. M., Cai, X.-D., McKay, D. M., Tintner, R., Frangione, B., et al. (1992) · Science · doi:10.1126/science.1439760 · Cited by 1,447 · cited 1×
“Amyloid precursor protein (APP) is a type I integral membrane protein that undergoes proteolysis via amyloidogenic or nonamyloidogenic pathways (Esch et al., 1990; Shoji et al., 1992; Haass and Selkoe, 1993; Haass et al., 1993; Jarrett et al., 1993).”
BackgroundUnbiased stereological estimation of the number of neurons in the human hippocampus
West, M. J., & Gundersen, H. J. G. (1990) · Journal of Comparative Neurology · doi:10.1002/cne.902960102 · Cited by 1,153 · cited 3×
“The sampling was optimized for maximal efficiency, with a final mean coefficient of error (West and Gundersen, 1990) Gundersen of 10% for all sections sampled.”
MethodAβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathology
Radde, R., Bolmont, T., Kaeser, S. A., Coomaraswamy, J., Lindau, D., Stoltze, L., Calhoun, M. E., Jäggi, F., Wolburg, H., Gengler, S., et al. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400784 · Cited by 986 · cited 1×
“Although CD11b and Iba-1 are pan-microglia markers, they have been useful in identifying A plaque-associated microglia in APP/PS1 mice (Radde et al., 2006; Combs, 2009).”
BackgroundAcute axonal injury in multiple sclerosis: Correlation with demyelination and inflammation
Bitsch, A. (2000) · Brain · doi:10.1093/brain/123.6.1174 · Cited by 898 · cited 2×
“Indeed, others have also demonstrated that APP immunoreactivity increases in microglia in rodent multiple sclerosis models (Gehrmann et al., 1995; Ferguson et al., 1997; Bitsch et al., 2000) or after traumatic brain injury (Sherriff et al.”
BackgroundCombs, C. K., Karlo, J. C., Kao, S.-C., & Landreth, G. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-04-01179.2001 · Cited by 721 · cited 2×
“Numerous studies have documented an ability of A peptide, in a range of multimeric states, to stimulate microglia to acquire a reactive phenotype (Combs et al., 1999, 2000, 2001a,b; Walsh et al., 2002; Sondag et al., 2009; Dhawan and Combs, 2012; Dhawan et al., 2012).”
BackgroundSelf-citationGeneration of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells.
Busciglio, J., Gabuzda, D. H., Matsudaira, P., & Yankner, B. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.2092 · Cited by 569 · cited 2×
“We recognize that A peptide may be secreted from a variety of cells, including neurons (Busciglio et al., 1993; Walsh et al., 2000; Takahashi et al., 2004), astrocytes (Siman et al., 1989; Haass et al., 1991), microglia (Banati et al., 1993b), or even peripheral cells for transport into the brain…”
BackgroundSelf-Assembly of Aβ 1 - 42 into Globular Neurotoxins
Chromy, B. A., Nowak, R. J., Lambert, M. P., Viola, K. L., Chang, L., Velasco, P. T., Jones, B. W., Fernandez, S. J., Lacor, P. N., Horowitz, P., et al. (2003) · Biochemistry · doi:10.1021/bi030029q · Cited by 522 · cited 1×
“Oligomers were generated from a modification as described by Chromy et al. (2003).”
MethodAmyloid β protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivo
Klyubin, I., Walsh, D. M., Lemere, C. A., Cullen, W. K., Shankar, G. M., Betts, V., Spooner, E. T., Jiang, L., Anwyl, R., Selkoe, D. J., et al. (2005) · Nature Medicine · doi:10.1038/nm1234 · Cited by 489 · cited 1×
“…others have shown that oligomeric A both in vitro (Roher et al., 1996; Lue et al., 1999; McLean et al., 1999) and in vivo (Cleary et al., 2005; Klyubin et al., 2005; Lesné et al., 2006) stimulate microglial activation, which is at least consistent with the notion that this form of the…”
BackgroundCombs, C. K., Johnson, D. E., Karlo, J. C., Cannady, S. B., & Landreth, G. E. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-02-00558.2000 · Cited by 483
Self-citationOligomerization of Alzheimer's β-Amyloid within Processes and Synapses of Cultured Neurons and Brain
Takahashi, R. H., Almeida, C. G., Kearney, P. F., Yu, F., Lin, M. T., Milner, T. A., & Gouras, G. K. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5167-03.2004 · Cited by 445 · cited 1×
“We recognize that A peptide may be secreted from a variety of cells, including neurons (Busciglio et al., 1993; Walsh et al., 2000; Takahashi et al., 2004), astrocytes (Siman et al., 1989; Haass et al., 1991), microglia (Banati et al., 1993b), or even peripheral cells for transport into the brain…”
BackgroundYoung-Pearse, T. L., Bai, J., Chang, R., Zheng, J. B., LoTurco, J. J., & Selkoe, D. J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4701-07.2007 · Cited by 369 · cited 1×
“The human APP plasmid (pCAX APP 695) was a gift from Dennis Selkoe and Tracy Young-Pearse (Addgene plasmid #30137; Young-Pearse et al., 2007) and the pCMV-RFP plasmid was a gift from Dr. Saobo Lei and Nicholas Cilz.”
MethodBeta amyloid oligomers and fibrils stimulate differential activation of primary microglia
Sondag, C. M., Dhawan, G., & Combs, C. K. (2009) · Journal of Neuroinflammation · doi:10.1186/1742-2094-6-1 · Cited by 295 · cited 3×
“Numerous studies have documented an ability of A peptide, in a range of multimeric states, to stimulate microglia to acquire a reactive phenotype (Combs et al., 1999, 2000, 2001a,b; Walsh et al., 2002; Sondag et al., 2009; Dhawan and Combs, 2012; Dhawan et al., 2012).”
BackgroundSelf-citationLorenzo, A., Yuan, M., Zhang, Z., Paganetti, P. A., Sturchler-Pierrat, C., Staufenbiel, M., Mautino, J., Vigo, F. S., Sommer, B., & Yankner, B. A. (2000) · Nature Neuroscience · doi:10.1038/74833 · Cited by 258
Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain
Giulian, D., Haverkamp, L. J., Li, J., Karshin, W. L., Yu, J., Tom, D., Li, X., & Kirkpatrick, J. B. (1995) · Neurochemistry International · doi:10.1016/0197-0186(95)00067-i · Cited by 242 · cited 1×
“…et al., 2005; Sondag et al., 2009; Dhawan and Combs, 2012; Dhawan et al., 2012) as well as many others (Banati et al., 1993a; Del Bo et al., 1995; Giulian et al., 1995; Klegeris et al., 1997; Combs et al., 1999, 2000, 2001a,b) have demonstrated robust microglial stimulation by fibrillar forms of…”
BackgroundWisniewski, H. M., Wegiel, J., Wang, K. C., & Lach, B. (1992) · Acta Neuropathologica · doi:10.1007/bf00311383 · Cited by 221
Chung, H., Brazil, M. I., Soe, T. T., & Maxfield, F. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32301 · Cited by 212
Puig, K. L., Floden, A. M., Adhikari, R., Golovko, M. Y., & Combs, C. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030378 · Cited by 152
Self-citationRodent Aβ Modulates the Solubility and Distribution of Amyloid Deposits in Transgenic Mice
Jankowsky, J. L., Younkin, L. H., Gonzales, V., Fadale, D. J., Slunt, H. H., Lester, H. A., Younkin, S. G., & Borchelt, D. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611050200 · Cited by 122 · cited 1×
“Indeed, although increased rodent A production does not appear to promote plaque deposition or gliosis, it has been reported to alter human A solubility and localization in transgenic mice (Jankowsky et al., 2007).”
BackgroundGrant, J. L., Ghosn, E. E. B., Axtell, R. C., Herges, K., Kuipers, H. F., Woodling, N. S., Andreasson, K., Herzenberg, L. A., Herzenberg, L. A., & Steinman, L. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004145 · Cited by 92 · cited 1×
“Indeed, prior work from other groups supports the idea that APP has a critical role in regulating overall immune phenotype (Grant et al., 2012; Kurnellas et al., 2014, 2015; Steinman et al., 2014).”
BackgroundAkaaboune, M., Allinquant, B., Farza, H., Roy, K., Magoul, R., Fiszman, M., Festoff, B. W., & Hantaı̈, D. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0834 · Cited by 58 · cited 1×
“…apart from the brain. including the spleen, liver, skin, intestine, kidney, adipose tissue, heart, muscle, and thymus (Selkoe et al., 1988; Joachim et al., 1989; Yamada et al., 1989; Sandbrink et al., 1994; Akaaboune et al., 2000; Herzog et al., 2004; Galloway et al., 2007; Lee et al., 2008).”
Amyloid precursor protein mediates proinflammatory activation of monocytic lineage cells
Sondag, C. M., & Combs, C. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313747200 · Cited by 56
Self-citationJanus faces of amyloid proteins in neuroinflammation
Steinman, L., Rothbard, J. B., & Kurnellas, M. P. (2014) · Journal of Clinical Immunology · doi:10.1007/s10875-014-0034-3 · Cited by 14 · cited 1×
“Indeed, prior work from other groups supports the idea that APP has a critical role in regulating overall immune phenotype (Grant et al., 2012; Kurnellas et al., 2014, 2015; Steinman et al., 2014).”
Background
Cited by
An Inflammation-Centric View of Neurological Disease: Beyond the Neuron
Skaper, S. D., Facci, L., Zusso, M., & Giusti, P. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00072 · Cited by 457
Govindpani, K., McNamara, L. G., Smith, N. R., Vinnakota, C., Waldvogel, H. J., Faull, R. L., & Kwakowsky, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050651 · Cited by 275
Alzheimer’s disease as an inflammatory disease
Bolós, M., Perea, J. R., & Avila, J. (2017) · BioMolecular Concepts · doi:10.1515/bmc-2016-0029 · Cited by 216
“This finding defines a novel function of APP in microglial regulation of the inflammatory response in AD (65).”
BackgroundPSEN1ΔE9, APPswe, and APOE4 Confer Disparate Phenotypes in Human iPSC-Derived Microglia
Konttinen, H., Cabral-da-Silva, M. E. C., Ohtonen, S., Wojciechowski, S., Shakirzyanova, A., Caligola, S., Giugno, R., Ishchenko, Y., Hernández, D., Fazaludeen, M. F., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.08.004 · Cited by 191
Young microglia restore amyloid plaque clearance of aged microglia
Daria, A., Colombo, A., Llovera, G., Hampel, H., Willem, M., Liesz, A., Haass, C., & Tahirovic, S. (2017) · The EMBO Journal · doi:10.15252/embj.201694591 · Cited by 174
Metadata
- Authors
- Manocha, G. D., Floden, A. M., Rausch, K., Kulas, J. A., McGregor, B. A., Rojanathammanee, L., Puig, K. R., Puig, K. L., Karki, S., Nichols, M. R., Darland, D. C., Porter, J. E., & Combs, C. K.
- Venue
- Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2016-08-10
- Volume
- 36
- Issue
- 32
- Pages
- 8471-8486
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2487210382
- Cited by
- 65
- References
- 25
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.